Dernièrement…

▶️ Retrouvez l’interview de @fabriceplasson pour @LyonDecideurs tournée lors de l’événement Lyon Pôle Bourse le 28 septembre dernier. #biocontrole #news #strategie

📣 Communiqué de Presse : https://bit.ly/3UjM17U
C’est officiel ! Les équipes d’#Amoéba sont heureuses de vous annoncer que l’#US EPA a approuvé l’utilisation du lysat d’amibe Willaertia magna C2c Maky comme #substance active utilisable en #agriculture aux #USA. 🌱

📣 Communiqué de Presse : https://bit.ly/3EWyVc2
🌱 #Amoéba a le plaisir d’annoncer la publication des #résultats d’#essais en champ 2022, une année record en nombre et en performance avec plus de 120 essais réalisés ou en cours à travers le monde

📣 Communiqué de Presse: https://bit.ly/3Th8RwF
💧#Amoéba retire son dossier #biocide au #Canada afin de concentrer nos ressources sur les priorités #stratégiques, telles que le déploiement de notre agent #biocontrôle en Europe et aux USA et du biocide en circuits fermés aux USA

Uncategorized


3 November 2022

US EPA approves Amoeba’s biocontrol solution in the US

Amoéba announces that the US EPA has approved the use of the lysate of Willaertia magna C2c Maky as an active substance for use in plant protection.


20 October 2022

Publication of 2022 field trial results

Amoéba announces the publication of its 2022 field trial results, a record year for the number and performance of field trials.


19 October 2022

Amoeba withdraws its biocide file in Canada

Amoéba announces that it will not pursue the application for its living amoeba-based biocide in Canada.


18 October 2022

Publication of a new scientific article in Plants

Amoéba announces the publication of a scientific article concerning the efficacy of its biocontrol products to fight potato late blight.


12 October 2022

US EPA approves tolerance exemption for the biocontrol active substance on foodstuffs

Amoéba informs that the US EPA approves tolerance exemption for the biocontrol active substance on foodstuffs.

 


3 October 2022

2022 Interim Financial Report

Amoéba announces today that it has published its Interim Financial Report for 2022.


29 September 2022

Amoeba announces its half-year results for 2022

Amoeba announces its half-year results for 2022


29 September 2022

US EPA about to approve Amoeba’s biocontrol solution for use in agriculture

Amoéba informs that the United States Environmental Protection Agency (US EPA) has made a positive pre-decisional determination following its assessment of the application dossier for the use of the Lysate of Willaertia magna C2c Maky as a biocontrol active ingredient (biopesticide) in agriculture.


15 September 2022

AMOEBA : insuance of the sixth tranche of 60 bonds convertible into shares

Amoéba announces the issuance of the sixth tranche of 60 bonds convertible into shares.


10 August 2022

US EPA about to approve Amoéba’s biocide for use in closed cooling systems

Amoéba informs that the US EPA has made a positive pre-decisional determination for the use of Amoéba’s biocide in closed cooling systems.


13 June 2022

Amoéba : Issuance of the 5th tranche of OCA

Amoéba announces the issuance of the fifth tranche of 60 bonds convertible into shares as part of its new bond financing with incentive program with Nice & Green S.A.


30 May 2022

Amoéba: US regulatory calendar update

Amoeba announces that the US EPA, in charge of the evaluation of the biocide and biocontrol applications in the United States, has requested an extension of the assessment period : the conclusions should now be available in the second half of 2022.


6 May 2022

Ordinary and extraordinary general meeting to be held on 24 May 2022

Amoéba announces the availability of preparatory documents for the General Assembly of May 24, 2022


3 May 2022

Amoeba: Malta recommends the non-approval of the “biocide” active substance for the European territory

Amoeba announces that the Maltese authority recommends the non-approval of the biocidal active substance for the European territory


25 April 2022

Amoéba: Austria recommends the approval of the biocontrol application in Europe

Amoéba announces that AGES, in charge of the application for approval of the biocontrol active substance “Lysate of Willaertia magna C2c Maky”, recommends its approval for use in plant protection on the European territory.


13 April 2022

Amoéba : Publication of the 2021 Universal Registration Document

Amoéba announces that the 2021 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers AMF) on April 12, 2022.


5 April 2022

Amoéba : Deferral of the 5th tranche of OCAs

Amoéba announces having exercised the suspension option relating to the issuance of the 5th tranche of OCAs, initially scheduled for April 5, 2022.


25 March 2022

Update of the European regulatory application calendar

Amoéba announces a report of the conclusion of the evaluation of the European biocide and biocontrol dossiers.


24 August 2021

Results of the 2nd cereal trial campaign

Amoeba confirms its biocontrol’s effectiveness against major cereal diseases


29 July 2021

Promising results of the Biocontrol-Grapewine application

Amoéba announces the results of the field trials 3rd campaign on grapes


5 July 2021

Postponement of the biocide active substance dossier

Malta commits to finalize the report in the 4th quarter of 2021


24 June 2021

Appointment of Philippe Dujardin to the Board of Directors

Philippe Dujardin replaces Pascal Reber as independent director


2 June 2021

General Meeting of June 24, 2021

Availability of the preparatory documents for the General meeting of 27 may 2021


27 May 2021

General Meeting second convocation

Due to a lack of quorum, the General Meeting is postponed to June 24, 2021


10 May 2021

General Assembly of May 27, 2021

Amoéba provides shareholders with preparatory documents


6 April 2021

Submission of the biocide application in the USA

Amoéba has submitted the application for approval of the biocidal active substance


6 April 2021

Massive new field trials campaign

Amoeba continues testing its biocontrol product in 2021


26 March 2021

Amoéba announces the 2020 financial year results

marked by the continued development of its biocidal and biocontrol applications


12 March 2021

Research partnership with the US group GOWAN COMPANY

Amoéba extends to the U.S.A. the testing of its biocontrol


10 March 2021

Appointment of Pierre Morgon to the Board of Directors

Amoéba has appointed Pierre Morgon as censor.


10 March 2021

Development and commercialization agreement

Signature of a Letter of Intent (LOI) with PHILAGRO France


18 December 2020

Signature of a non-exclusive development and marketing agreement

in Switzerland with Stähler for its vine Bioncontrol product.